Didier Allaer
Directeur Général chez Diagenode SA
Profil
Didier Allaer is the founder and Chief Executive Officer of Diagenode SA since 2003.
He is currently the Chairman of Sagitta Biotech SA since 2023 and a Director at Labage SA and THERAtRAME SA.
Postes actifs de Didier Allaer
| Sociétés | Poste | Début |
|---|---|---|
Diagenode SA
 Diagenode SA Medical SpecialtiesHealth Technology Diagenode SA provides solutions for epigenetics research, biological sample preparation, and diagnostics assays. It offers Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company was founded in 2003 and is headquartered in Seraing, Belgium. | Directeur Général | 01/01/2003 |
Labage SA
 Labage SA Packaged SoftwareTechnology Services Labage SA engages in the development of software solutions and web-based tools for the management of technical expertise, research and development data, and resources using collective intelligence technologies. Its main product Benchsys is a software constructed as an adaptive case management system from the ground up, with the flexibility in mind and the human being right in the centre of user organization. The company was founded by Andre Renard and Christian Renard in 2002 and is headquartered in Liege, Belgium. | Directeur/Membre du Conseil | - |
THERAtRAME SA
 THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Directeur/Membre du Conseil | - |
Sagitta Biotech SA
 Sagitta Biotech SA Miscellaneous Commercial ServicesCommercial Services Sagitta Biotech SA provides research and development of biotechnology. The company is based in Liege, Belgium. The Belgian company was founded in 2019. Benjamin Damien has been the CEO of the company since 2019. | Président | 16/01/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Diagenode SA
Diagenode SA Medical SpecialtiesHealth Technology Diagenode SA provides solutions for epigenetics research, biological sample preparation, and diagnostics assays. It offers Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company was founded in 2003 and is headquartered in Seraing, Belgium. | Health Technology |
Labage SA
Labage SA Packaged SoftwareTechnology Services Labage SA engages in the development of software solutions and web-based tools for the management of technical expertise, research and development data, and resources using collective intelligence technologies. Its main product Benchsys is a software constructed as an adaptive case management system from the ground up, with the flexibility in mind and the human being right in the centre of user organization. The company was founded by Andre Renard and Christian Renard in 2002 and is headquartered in Liege, Belgium. | Technology Services |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Health Technology |
Sagitta Biotech SA
Sagitta Biotech SA Miscellaneous Commercial ServicesCommercial Services Sagitta Biotech SA provides research and development of biotechnology. The company is based in Liege, Belgium. The Belgian company was founded in 2019. Benjamin Damien has been the CEO of the company since 2019. | Commercial Services |
